Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer’s Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer’s Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume -, Issue -, Pages 1-17
Publisher
IOS Press
Online
2021-04-07
DOI
10.3233/jad-201054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of the effect of lemborexant with placebo and zolpidem tartrate extended release on sleep architecture in older adults with insomnia disorder
- (2021) Margaret Moline et al. Journal of Clinical Sleep Medicine
- Circadian and sleep dysfunction in Alzheimer’s disease
- (2020) Md. Sahab Uddin et al. AGEING RESEARCH REVIEWS
- Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
- (2020) Mikko Kärppä et al. SLEEP
- Evaluating Circadian Dysfunction in Mouse Models of Alzheimer’s Disease: Where Do We Stand?
- (2020) Patrick W. Sheehan et al. Frontiers in Neuroscience
- Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation
- (2019) Carsten Theodor Beuckmann et al. SLEEP
- SILK studies — capturing the turnover of proteins linked to neurodegenerative diseases
- (2019) Ross W. Paterson et al. Nature Reviews Neurology
- Profound degeneration of wake-promoting neurons in Alzheimer's disease
- (2019) Jun Oh et al. Alzheimers & Dementia
- Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice
- (2019) Carrie E Mahoney et al. SLEEP
- Disposition and metabolism of [14C]lemborexant, a novel dual orexin receptor antagonist, in rats and monkeys
- (2018) Takashi Ueno et al. XENOBIOTICA
- Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease
- (2018) Erik S. Musiek et al. JAMA Neurology
- On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers
- (2018) Annemiek Vermeeren et al. SLEEP
- Optogenetic Investigation of Arousal Circuits
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study
- (2017) Patricia Murphy et al. Journal of Clinical Sleep Medicine
- In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist
- (2017) Carsten Theodor Beuckmann et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Hypothalamic regulation of the sleep/wake cycle
- (2017) Daisuke Ono et al. NEUROSCIENCE RESEARCH
- Discovery of (1R,2S)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist
- (2015) Yu Yoshida et al. JOURNAL OF MEDICINAL CHEMISTRY
- American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
- (2015) JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- EEG Spectral Features Discriminate between Alzheimer’s and Vascular Dementia
- (2015) Emanuel Neto et al. Frontiers in Neurology
- Hypnotics and the Occurrence of Bone Fractures in Hospitalized Dementia Patients: A Matched Case-Control Study Using a National Inpatient Database
- (2015) Hiroyuki Tamiya et al. PLoS One
- Design, synthesis, and structure–activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists
- (2014) Yu Yoshida et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer Disease
- (2014) Claudio Liguori et al. JAMA Neurology
- EEG in Silent Small Vessel Disease
- (2013) Rishi V. A. Sheorajpanday et al. JOURNAL OF CLINICAL NEUROPHYSIOLOGY
- Sleep Quality and Preclinical Alzheimer Disease
- (2013) Yo-El S. Ju et al. JAMA Neurology
- The SAMP8 Mouse: A Model to Develop Therapeutic Interventions for Alzheimers Disease
- (2012) John E. Morley et al. CURRENT PHARMACEUTICAL DESIGN
- Sleep Disturbance in Dementia with Lewy Bodies and Alzheimer’s Disease: A Multicenter Analysis
- (2011) Donald L. Bliwise et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1
- (2011) Bettina Platt et al. PLoS One
- Aligning strategies for using EEG as a surrogate biomarker: A review of preclinical and clinical research
- (2010) Steven C. Leiser et al. BIOCHEMICAL PHARMACOLOGY
- Circadian rhythms of basal orexin levels in the hypothalamus are not influenced by an impaired corticotropin-releasing hormone receptor type 1 system
- (2009) Thomas Fenzl et al. BEHAVIOURAL BRAIN RESEARCH
- Amyloid- Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle
- (2009) J.-E. Kang et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started